Methodology · revision 1.4

A bio age you can argue with.

13
domains modelled. Fitness, cardiovascular, sleep, body composition, cognitive, physical function, labs, inflammation, clinical, genetic, family history, mental health, lifestyle.
~50
weighted coefficients. 13 carry an effect size from a published outcome study. Most of the rest follow clinical guideline thresholds or reference ranges, and a few are our own judgement.
±0.5y
day-to-day stability. An exponential moving average (α = 0.35), regression-tested on noisy realistic input, keeps the number from flickering.

The approach in one paragraph

We don't predict mortality. We predict physiological age - the age at which someone with median health metrics would carry the same readings you do. Each of 13 domains emits a "years older or younger than chronological" signal, anchored to published research where it exists. Where a weight comes from a published all-cause hazard ratio, it is converted to years with the Gompertz mortality doubling time (about 11.5 × ln HR), so the result reads as a mortality-equivalent effective age; it is not a model trained on death records. Domains compose additively, with safety clamps so no single signal can dominate, and a confidence score so a sparse-data user knows their estimate is provisional. Day-to-day stability is enforced by an exponential moving average (α = 0.35) that's regression-tested to keep variance under 0.5 years on realistic noisy input.

This page is the public version of our internal methodology document. It's published - rather than kept internal - because the alternative is a black-box bio-age number, and health-tech apps that hide their math should not be trusted.

How the weights are sourced. Of roughly 50 weighted coefficients, 13 carry an effect size from a published outcome study. VO₂ max, resting heart rate and former smoking land close to what their studies imply; most of the others are deliberately weighted below it, so that correlated signals (VO₂, steps, resting HR, HRV) don't double-count in an additive model. Most of the rest follow clinical guideline thresholds or reference ranges, and a few are our own product judgement.

1 · Fitness

VO₂ max - the strongest single signal

Predicted VO₂ max for your age, sex, and weight uses the Jackson non-exercise estimate. Years delta is then −1.61 · (measured − expected) / 3.5, clamped to ±6 years.

Mandsager K et al. Association of Cardiorespiratory Fitness with Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open 2018;1(6):e183605.
A 1-MET (3.5 ml/kg/min) advantage over expected mapped to ~12% lower all-cause mortality; converted to ~1.6 years of physiological-age equivalent.

Steps and active minutes

Steps score on a smooth curve against the log of your daily average: up to +3 years at or under 3,000 steps, zero at 8,000, then credit, up to −2 years from 12,000. From 65 the same shape sits lower (zero at 6,000, −2 years from 9,000), and ages 55–65 blend between the two, so neither one extra step nor a birthday moves the number in a jump.

Saint-Maurice PF et al. Association of Daily Step Count and Step Intensity with Mortality Among US Adults. JAMA 2020;323(12):1151-1160.

Cumulative fitness - capacity + behavior

VO₂ measures cardiorespiratory capacity (peak aerobic potential); steps and active minutes measure behavior (habitual movement). They have meaningfully independent contributions.

Stamatakis E et al. Joint associations of objectively-assessed physical activity and cardiorespiratory fitness with all-cause and cardiovascular mortality. BMJ 2019;366:l4570.
Combined high-fitness + high-activity stratum had the largest mortality reduction (HR ≈ 0.45 vs sedentary low-fit). "High-fit / low-active" was substantially worse than "high-fit / high-active".

The engine combines:

DriverRangeWhen it fires
VO₂ max±6yAlways preferred when present
Cycling FTP±6yOnly when VO₂ absent
Steps + active-min±2.5y full / ±1.25y discountedAlways when data present
Self-reported activity±2yOnly when neither capacity nor behavior fires
Zone 2 minutes bonus−0.4y additiveWhen any primary path fired

When both capacity and behavior are present, behavior is discounted by min(0.5, |capacityDelta| / 6.0) - Stamatakis 2019's ~50% overlap. The combined sum is clamped at ±7y.

2 · Cardiovascular & autonomic

Blood pressure

Bands match the ACC/AHA 2017 hypertension guideline. The protective athletic-low band (90-114 / 60-74) was added on the back of the SPRINT trial.

ReadingYears delta
90-114 / 60-74 (athletic-low)−0.3
<120/80 (normal)0
120-129 / <80 (elevated)+0.5
≥130/80 (Stage 1)+1.5
≥140/90 (Stage 2)+3.0
>180/120 (severe)+4.5
Whelton PK et al. 2017 ACC/AHA Guideline for High Blood Pressure in Adults. JACC 2018;71:e127-e248.

Resting heart rate

Bands progress from −1.0y at ≤55 bpm to +3.3y at ~100 bpm.

Saxena A et al. Resting Heart Rate and Mortality. Eur Heart J 2013 - pooled analysis: hazard ratio ~1.09 per 10 bpm above 65.

Heart rate variability (RMSSD)

Hillebrand S et al. Heart Rate Variability and First Cardiovascular Event in Populations Without Known Cardiovascular Disease: meta-analysis and dose-response. Europace 2013;15:742-749.

3 · Sleep & recovery

Sleep duration uses an inverted-U curve with its optimum at 7-8.5h, with bands grounded in:

Yin J et al. Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. J Am Heart Assoc 2017;6:e005947.

Sleep efficiency (% of time-in-bed actually asleep), bedtime regularity, and time-in-deep-sleep + REM each contribute additional small deltas. The sleep domain as a whole is bounded at −1 / +5 years.

4 · Body composition

Body fat % bands are sex-specific and preferred when available. BMI is the fallback, following the J-curve: a small protective band at 22-24, penalties below 18.5 and above 25. Waist circumference is a separate visceral-fat signal using the WHO absolute thresholds: 94 / 102 cm for men and 80 / 88 cm for women (above the first is a small penalty, above the second a larger one).

Flegal KM et al. Association of all-cause mortality with overweight and obesity using standard BMI categories: a systematic review and meta-analysis. JAMA 2013;309(1):71-82.

5 · Cognitive

The in-app cognitive battery (reaction time, word recall, spatial memory, symbol match) emits a small (±2y) bonus or penalty, weighted by how much the user's score deviates from age-matched norms. This is a deliberately modest contribution - single-session cognitive scores have high variance.

6 · Physical function

Grip strength, sit-to-stand reps, and balance time. Each is a strong independent predictor of mortality in older adults; in younger users they're smaller signals.

Leong DP et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 2015;386(9990):266-273.
Each 5kg decrement in grip strength was associated with a 16% increase in all-cause mortality.

7 · Lab biomarkers (AI-aggregated)

When you upload a lab report (PDF or photo), an AI pass reads it. Four markers are pulled out and scored individually with published bands (HbA1c, ApoB, Lp(a) and fasting insulin; see §9). Separately, the AI returns one aggregate years estimate for the report as a whole, which is how an epigenetic-clock or telomere result enters the model. That aggregate is weighted by how recent the test is (full weight under 6 months, dropped after 18) and capped at ±15 years.

8 · Inflammation (hsCRP)

High-sensitivity CRP is the single inflammation marker in the model.

Ridker PM. A Test in Context: High-Sensitivity C-Reactive Protein. JACC 2016;67(6):712-723.
hsCRP <1 mg/L low risk; 1-3 mg/L average; >3 mg/L elevated; >10 mg/L acute-process flag (excluded from chronic-disease estimation).

9 · Lab markers - structured per-marker

Four markers are scored individually, each with its own band table and the same 18-month freshness weight. Together they are capped at −1.5 / +5 years.

ApoB

Sniderman AD et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol 2019;4(12):1287-1295.
ApoB outperforms LDL-C as a CV-risk predictor; targets <80 mg/dL standard, <60 mg/dL aggressive.

Bands (mg/dL): <70 −0.3y · 70-99 0 · 100-129 +0.7y · ≥130 +1.5y.

HbA1c

Selvin E et al. Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults. NEJM 2010;362:800-811.

Bands (%): <5.7 0 · 5.7-5.9 +0.4y · 6.0-6.4 +0.8y · 6.5-7.4 +1.5y · 7.5-8.9 +2.5y · ≥9.0 +3.5y.

Lp(a)

Genetic, single-test. Bands (mg/dL): <30 0 · 30-49 +0.3y · 50-99 +0.8y · ≥100 +1.5y. Kronenberg F et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J 2022;43(39):3925-3946.

Fasting insulin

Bands (μIU/mL): <10 0 · 10-14 +0.4y · 15-19 +0.8y · ≥20 +1.2y. Fasting hyperinsulinaemia tends to precede a rise in glucose. Reaven GM. The metabolic syndrome or the insulin resistance syndrome? Endocrinol Metab Clin North Am 2004;33(2):283-303.

Other markers on a report (vitamin D, ferritin, liver and kidney panels) are not scored individually by the engine.

10 · Genetic (APOE ε4)

When a user uploads 23andMe / AncestryDNA raw data, the engine reads APOE ε4 status. e3/e3 baseline; one ε4 copy +0.5y; two copies (e4/e4) +2.0y. This is a deliberately small contribution - APOE is correlative, not deterministic.

Liu C-C et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 2013;9:106-118.

11 · Family history (parental longevity)

Self-reported parental longevity, scored as one whole-family category: both parents lived or are living past 90, −1.0y; both past 80, −0.5y; typical, 0; one parent died before 70, +0.5y; both parents died before 70, +1.5y.

Sebastiani P et al. Families enriched for exceptional longevity also have increased health-span. Front Public Health 2013;1:38.

12 · Mental health

PHQ-9 (depression), GAD-7 (anxiety), and PSS-10 (perceived stress) - each user-administered in-app. Major depression is associated with ~+1.7y physiological age; severe anxiety adds another small layer; high perceived stress is a separate signal.

Han LKM et al. Contributing factors to advanced brain aging in depression and anxiety disorders. Translational Psychiatry 2021;11:402.

13 · Clinical flags

Smoking: current +8y, former +2y (no quit-year tiers). Chronic conditions: +1 / +2 / +3y for one, two, or three or more reported, plus up to +2y more for the most serious cardiometabolic ones (diabetes or pre-diabetes, heart disease, and high blood pressure when no measured BP is already scored). The clinical domain is capped at +10y. Severe BP (>180/120) also surfaces with a "seek prompt review" message - at that level, the algorithm should not silently average the data into a score.

Composite, caps, and smoothing

Domains compose additively, with two safety mechanisms:

  1. Per-domain caps. Each domain has its own bound: fitness ±7 years, cardiovascular −2 / +6, sleep −1 / +5, cognitive ±2, physical function −2.5 / +3.5, mental health 0 / +2.5, the four structured lab markers −1.5 / +5, clinical −0.5 / +10. The AI lab aggregate is the widest at ±15, because a measured clock can genuinely sit that far out. Prevents one outlier signal from dominating.
  2. Two buckets, then a total clamp. The lifestyle domains (fitness, cardiovascular, sleep, body composition, mental health, clinical) are summed and capped by age: −3 / +8 years at 22 and under, widening in a straight line to −18 / +20 at 60 and over, because a 25-year-old can't plausibly be a decade younger on lifestyle alone. Measured biology (labs, inflammation, cognitive, physical function, genetic, family history) is summed and clamped at ±25. The combined result is bounded at −30 / +35 years, and bio age never goes below 18.

Day-to-day stability is enforced by an exponential moving average (α = 0.35) that's regression-tested on noisy realistic input. The smoother lives in BioAgeSmoother.swift and is mirrored on the server as a Postgres RPC for cross-platform parity.

Confidence & uncertainty

Every reading carries a confidence score (0-1) computed from how many domains had data. Sparse-data users see a "provisional" badge on their bio age until enough domains light up. The confidence breakdown is visible in the in-app Bio Age Breakdown sheet, alongside the per-domain contribution chart.

What this isn't

  • Not a mortality prediction. Mortality models (e.g. Klemera-Doubal, PhenoAge) train on death-event data; we don't. Where our years come from published hazard ratios, they are translated into a mortality-equivalent effective age, not a prognosis.
  • Not yet validated against outcomes or an epigenetic clock. Since September 2026 the app logs, for members who upload a DNA-methylation result, how far the engine (with that lab result left out) sits from their clock age. We'll publish those numbers once the sample is big enough to mean something.
  • Not a methylation clock. Methylation clocks (Horvath, GrimAge) measure DNA methylation directly. This model uses behavioral, physiological, and biomarker proxies.
  • Not a disease diagnosis. A high bio age doesn't mean you have a condition; it means signals are pointing in a direction worth understanding.
  • Not personalised therapy. Recommendations are population-level. For anything clinically significant, see a doctor.

Methodology v1.4, last revised 2026-10-03. The full coefficient-level document, with every band and citation, is available on request: hi@thier.app.

Signed off

Read it. Argue with it. Then go see your number.

The point of publishing the weights is that you don't have to take my word for any of it. Read the paper. Check the threshold. If you find a coefficient that disagrees with the literature, tell me - I'll fix it. The methodology is a living document; the engine is a single Swift package; both are open to argument.

- Steven